GIORDANO, MIRELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.218
AS - Asia 1.223
EU - Europa 888
SA - Sud America 204
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.639
Nazione #
US - Stati Uniti d'America 2.172
SG - Singapore 449
CN - Cina 325
IT - Italia 261
HK - Hong Kong 232
SE - Svezia 181
DE - Germania 178
BR - Brasile 169
VN - Vietnam 55
CI - Costa d'Avorio 54
GB - Regno Unito 53
IN - India 38
BG - Bulgaria 37
CA - Canada 36
RU - Federazione Russa 36
FI - Finlandia 29
FR - Francia 26
TR - Turchia 23
JP - Giappone 22
AT - Austria 19
NG - Nigeria 19
PL - Polonia 18
SN - Senegal 18
AR - Argentina 15
BD - Bangladesh 13
IQ - Iraq 10
NL - Olanda 10
UA - Ucraina 8
ID - Indonesia 7
KR - Corea 7
LT - Lituania 6
SA - Arabia Saudita 6
ES - Italia 5
IE - Irlanda 5
MX - Messico 5
PK - Pakistan 5
AZ - Azerbaigian 4
JO - Giordania 4
PE - Perù 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
CL - Cile 3
EC - Ecuador 3
IL - Israele 3
TH - Thailandia 3
VE - Venezuela 3
BE - Belgio 2
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EU - Europa 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TW - Taiwan 1
Totale 4.639
Città #
Ashburn 339
Dallas 262
Singapore 251
Hong Kong 221
Santa Clara 180
Chandler 172
Fairfield 139
Woodbridge 135
Houston 85
Shanghai 79
Beijing 76
Pisa 65
New York 63
Seattle 61
Los Angeles 58
Abidjan 54
Cambridge 53
Wilmington 48
Boardman 46
Florence 38
Sofia 37
Princeton 34
Bremen 33
Munich 32
Lawrence 30
Ann Arbor 26
Frankfurt am Main 26
London 23
Serra 21
Milan 20
Lagos 19
Tokyo 19
Dakar 18
Warsaw 18
Turku 17
Istanbul 16
Medford 16
Ottawa 16
San Diego 16
São Paulo 16
Boulder 15
Vienna 15
Des Moines 12
Ogden 12
Buffalo 11
Redondo Beach 11
Genoa 10
Hefei 10
Ho Chi Minh City 10
Montreal 10
Nanjing 9
Turin 9
Cascina 8
Dong Ket 8
Fuzhou 8
Phoenix 8
Washington 8
Hanoi 7
Seoul 7
Denver 6
Düsseldorf 6
Porto Alegre 6
Baghdad 5
Boston 5
Dublin 5
Kent 5
Nuremberg 5
Quanzhou 5
Rio de Janeiro 5
Rome 5
Amman 4
Atlanta 4
Baku 4
Bologna 4
Chennai 4
Chicago 4
Dhaka 4
Guangzhou 4
Haiphong 4
Nanchang 4
Paris 4
Qingdao 4
Redmond 4
Tashkent 4
Toronto 4
Ankara 3
Bangkok 3
Brooklyn 3
Council Bluffs 3
Fortaleza 3
Gargallo 3
Hangzhou 3
Helsinki 3
Jakarta 3
Jeddah 3
Jinan 3
Nürnberg 3
Pune 3
Riyadh 3
Shenyang 3
Totale 3.229
Nome #
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 195
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 192
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction 187
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 181
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma 173
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 163
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 158
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 150
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 143
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 142
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 139
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 132
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 131
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 126
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 124
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 117
null 116
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness 116
Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications 112
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series 107
A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma 106
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 98
null 98
Molecular Pathology of Acinar Cystic Transformation 98
Expression of miRNA-25 in young and old lung adenocarcinoma 95
Molecular Subtypes of Pancreatic Ductal Adenocarcinoma 94
Molecular Pathology of Mucinous Cystic Neoplasms 93
Molecular Pathology of Acinar Cell Carcinoma 92
Molecular Pathology of Serous Cystic Neoplasms 91
Molecular Pathology of Neuroendocrine Carcinoma 87
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 85
Molecular Pathology of Pancreatic Intraepithelial Neoplasms 84
Molecular Pathology of Neuroendocrine Tumors 84
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 83
Molecular Pathology of Intraductal Papillary Mucinous Neoplasms 81
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 80
null 78
Molecular Pathology of Solid Pseudopapillary Neoplasms 78
Molecular Pathology of Pancreatic Ductal Adenocarcinoma 77
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value 73
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy 70
null 15
Totale 4.744
Categoria #
all - tutte 15.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 16 4 17 16 15 5 35
2021/2022293 5 7 0 4 28 69 17 16 15 29 22 81
2022/2023641 71 94 41 69 58 68 6 45 139 5 40 5
2023/2024377 12 28 41 35 55 79 27 13 11 12 28 36
2024/20251.427 43 53 13 81 126 150 134 56 155 160 143 313
2025/20261.098 144 199 257 137 234 127 0 0 0 0 0 0
Totale 4.744